Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Short term Debt (2016 - 2025)

Collegium Pharmaceutical has reported Short term Debt over the past 10 years, most recently at $17.6 million for Q4 2025.

  • Quarterly results put Short term Debt at $17.6 million for Q4 2025, down 39.34% from a year ago — trailing twelve months through Dec 2025 was $17.6 million (down 39.34% YoY), and the annual figure for FY2025 was $17.6 million, down 39.34%.
  • Short term Debt for Q4 2025 was $17.6 million at Collegium Pharmaceutical, down from $64.6 million in the prior quarter.
  • Over the last five years, Short term Debt for COLL hit a ceiling of $183.3 million in Q1 2023 and a floor of $17.6 million in Q4 2025.
  • Median Short term Debt over the past 5 years was $82.3 million (2022), compared with a mean of $106.1 million.
  • Biggest five-year swings in Short term Debt: skyrocketed 236.07% in 2022 and later tumbled 84.21% in 2024.
  • Collegium Pharmaceutical's Short term Debt stood at $48.4 million in 2021, then skyrocketed by 236.07% to $162.5 million in 2022, then rose by 12.82% to $183.3 million in 2023, then tumbled by 84.21% to $29.0 million in 2024, then plummeted by 39.34% to $17.6 million in 2025.
  • The last three reported values for Short term Debt were $17.6 million (Q4 2025), $64.6 million (Q3 2025), and $64.6 million (Q2 2025) per Business Quant data.